Report Detail

Pharma & Healthcare Global Short Bowel Syndrome Market Professional Survey Report 2019

  • RnM3792611
  • |
  • 30 September, 2019
  • |
  • Global
  • |
  • 105 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.

The global Short Bowel Syndrome market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Short Bowel Syndrome volume and value at global level, regional level and company level. From a global perspective, this report represents overall Short Bowel Syndrome market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Short Bowel Syndrome in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Short Bowel Syndrome manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Shire
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
GLP-2
Growth Hormone
Glutamine
Others

Segment by Application
Hospitals
Clinics


Table of Contents

    Executive Summary

      1 Industry Overview of Short Bowel Syndrome

      • 1.1 Definition of Short Bowel Syndrome
      • 1.2 Short Bowel Syndrome Segment by Type
        • 1.2.1 Global Short Bowel Syndrome Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 GLP-2
        • 1.2.3 Growth Hormone
        • 1.2.4 Glutamine
        • 1.2.5 Others
      • 1.3 Short Bowel Syndrome Segment by Applications
        • 1.3.1 Global Short Bowel Syndrome Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
      • 1.4 Global Short Bowel Syndrome Overall Market
        • 1.4.1 Global Short Bowel Syndrome Revenue (2014-2025)
        • 1.4.2 Global Short Bowel Syndrome Production (2014-2025)
        • 1.4.3 North America Short Bowel Syndrome Status and Prospect (2014-2025)
        • 1.4.4 Europe Short Bowel Syndrome Status and Prospect (2014-2025)
        • 1.4.5 China Short Bowel Syndrome Status and Prospect (2014-2025)
        • 1.4.6 Japan Short Bowel Syndrome Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Short Bowel Syndrome Status and Prospect (2014-2025)
        • 1.4.8 India Short Bowel Syndrome Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Short Bowel Syndrome
      • 2.3 Manufacturing Process Analysis of Short Bowel Syndrome
      • 2.4 Industry Chain Structure of Short Bowel Syndrome

      3 Development and Manufacturing Plants Analysis of Short Bowel Syndrome

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Short Bowel Syndrome Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Short Bowel Syndrome
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Short Bowel Syndrome Production and Capacity Analysis
      • 4.2 Short Bowel Syndrome Revenue Analysis
      • 4.3 Short Bowel Syndrome Price Analysis
      • 4.4 Market Concentration Degree

      5 Short Bowel Syndrome Regional Market Analysis

      • 5.1 Short Bowel Syndrome Production by Regions
        • 5.1.1 Global Short Bowel Syndrome Production by Regions
        • 5.1.2 Global Short Bowel Syndrome Revenue by Regions
      • 5.2 Short Bowel Syndrome Consumption by Regions
      • 5.3 North America Short Bowel Syndrome Market Analysis
        • 5.3.1 North America Short Bowel Syndrome Production
        • 5.3.2 North America Short Bowel Syndrome Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Short Bowel Syndrome Import and Export
      • 5.4 Europe Short Bowel Syndrome Market Analysis
        • 5.4.1 Europe Short Bowel Syndrome Production
        • 5.4.2 Europe Short Bowel Syndrome Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Short Bowel Syndrome Import and Export
      • 5.5 China Short Bowel Syndrome Market Analysis
        • 5.5.1 China Short Bowel Syndrome Production
        • 5.5.2 China Short Bowel Syndrome Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Short Bowel Syndrome Import and Export
      • 5.6 Japan Short Bowel Syndrome Market Analysis
        • 5.6.1 Japan Short Bowel Syndrome Production
        • 5.6.2 Japan Short Bowel Syndrome Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Short Bowel Syndrome Import and Export
      • 5.7 Southeast Asia Short Bowel Syndrome Market Analysis
        • 5.7.1 Southeast Asia Short Bowel Syndrome Production
        • 5.7.2 Southeast Asia Short Bowel Syndrome Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Short Bowel Syndrome Import and Export
      • 5.8 India Short Bowel Syndrome Market Analysis
        • 5.8.1 India Short Bowel Syndrome Production
        • 5.8.2 India Short Bowel Syndrome Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Short Bowel Syndrome Import and Export

      6 Short Bowel Syndrome Segment Market Analysis (by Type)

      • 6.1 Global Short Bowel Syndrome Production by Type
      • 6.2 Global Short Bowel Syndrome Revenue by Type
      • 6.3 Short Bowel Syndrome Price by Type

      7 Short Bowel Syndrome Segment Market Analysis (by Application)

      • 7.1 Global Short Bowel Syndrome Consumption by Application
      • 7.2 Global Short Bowel Syndrome Consumption Market Share by Application (2014-2019)

      8 Short Bowel Syndrome Major Manufacturers Analysis

      • 8.1 Shire
        • 8.1.1 Shire Short Bowel Syndrome Production Sites and Area Served
        • 8.1.2 Shire Product Introduction, Application and Specification
        • 8.1.3 Shire Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Merck
        • 8.2.1 Merck Short Bowel Syndrome Production Sites and Area Served
        • 8.2.2 Merck Product Introduction, Application and Specification
        • 8.2.3 Merck Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Emmaus Life Sciences
        • 8.3.1 Emmaus Life Sciences Short Bowel Syndrome Production Sites and Area Served
        • 8.3.2 Emmaus Life Sciences Product Introduction, Application and Specification
        • 8.3.3 Emmaus Life Sciences Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Nutrinia
        • 8.4.1 Nutrinia Short Bowel Syndrome Production Sites and Area Served
        • 8.4.2 Nutrinia Product Introduction, Application and Specification
        • 8.4.3 Nutrinia Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 GlyPharma Therapeutics
        • 8.5.1 GlyPharma Therapeutics Short Bowel Syndrome Production Sites and Area Served
        • 8.5.2 GlyPharma Therapeutics Product Introduction, Application and Specification
        • 8.5.3 GlyPharma Therapeutics Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 OxThera
        • 8.6.1 OxThera Short Bowel Syndrome Production Sites and Area Served
        • 8.6.2 OxThera Product Introduction, Application and Specification
        • 8.6.3 OxThera Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Ardelyx
        • 8.7.1 Ardelyx Short Bowel Syndrome Production Sites and Area Served
        • 8.7.2 Ardelyx Product Introduction, Application and Specification
        • 8.7.3 Ardelyx Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Sancilio & Company
        • 8.8.1 Sancilio & Company Short Bowel Syndrome Production Sites and Area Served
        • 8.8.2 Sancilio & Company Product Introduction, Application and Specification
        • 8.8.3 Sancilio & Company Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Naia Pharmaceuticals
        • 8.9.1 Naia Pharmaceuticals Short Bowel Syndrome Production Sites and Area Served
        • 8.9.2 Naia Pharmaceuticals Product Introduction, Application and Specification
        • 8.9.3 Naia Pharmaceuticals Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Zealand Pharma
        • 8.10.1 Zealand Pharma Short Bowel Syndrome Production Sites and Area Served
        • 8.10.2 Zealand Pharma Product Introduction, Application and Specification
        • 8.10.3 Zealand Pharma Short Bowel Syndrome Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Short Bowel Syndrome Market

      • 9.1 Global Short Bowel Syndrome Market Trend Analysis
        • 9.1.1 Global Short Bowel Syndrome Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Short Bowel Syndrome Regional Market Trend
        • 9.2.1 North America Short Bowel Syndrome Forecast 2019-2025
        • 9.2.2 Europe Short Bowel Syndrome Forecast 2019-2025
        • 9.2.3 China Short Bowel Syndrome Forecast 2019-2025
        • 9.2.4 Japan Short Bowel Syndrome Forecast 2019-2025
        • 9.2.5 Southeast Asia Short Bowel Syndrome Forecast 2019-2025
        • 9.2.6 India Short Bowel Syndrome Forecast 2019-2025
      • 9.3 Short Bowel Syndrome Market Trend (Product Type)
      • 9.4 Short Bowel Syndrome Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Short Bowel Syndrome Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Short Bowel Syndrome. Industry analysis & Market Report on Short Bowel Syndrome is a syndicated market report, published as Global Short Bowel Syndrome Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Short Bowel Syndrome market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,800.00
        4,200.00
        5,600.00
        3,269.00
        4,903.50
        6,538.00
        552,790.00
        829,185.00
        1,105,580.00
        292,005.00
        438,007.50
        584,010.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report